The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 728K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

16 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Inhibition of plasma lipid oxidation induced by peroxyl radicals, peroxynitrite, hypochlorite, 15-lipoxygenase, and singlet oxygen by clinical drugs.EBI
Kyoto Prefectural University of Medicine
Identification of SNAIL1 Peptide-Based Irreversible Lysine-Specific Demethylase 1-Selective Inactivators.EBI
Kyoto Prefectural University of Medicine
Identification of Jumonji AT-Rich Interactive Domain 1A Inhibitors and Their Effect on Cancer Cells.EBI
Kyoto Prefectural University of Medicine
Identification of the KDM2/7 histone lysine demethylase subfamily inhibitor and its antiproliferative activity.EBI
Kyoto Prefectural University of Medicine
Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries.EBI
Kyoto Prefectural University of Medicine
Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors.EBI
Kyoto Prefectural University of Medicine
Lysine demethylases inhibitors.EBI
Kyoto Prefectural University of Medicine
Design, synthesis, and biological evaluation of phenylcyclopropylamine-entinostat conjugates that selectively target cancer cells.EBI
Kyoto Prefectural University of Medicine
Identification of Potent and Selective Inhibitors of Fat Mass Obesity-Associated Protein Using a Fragment-Merging Approach.EBI
Kyoto Prefectural University of Medicine
Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates.EBI
Kyoto Prefectural University of Medicine
Discovery of Second Generation RORγ Inhibitors Composed of an Azole Scaffold.EBI
Kyoto Prefectural University of Medicine
Identification of novel lysine demethylase 5-selective inhibitors by inhibitor-based fragment merging strategy.EBI
Kyoto Prefectural University of Medicine
Identification of ortho-hydroxy anilide as a novel scaffold for lysine demethylase 5 inhibitors.EBI
Kyoto Prefectural University of Medicine
Identification of Diketopiperazine-Containing 2-Anilinobenzamides as Potent Sirtuin 2 (SIRT2)-Selective Inhibitors Targeting the "Selectivity Pocket", Substrate-Binding Site, and NADEBI
Kyoto Prefectural University of Medicine
Effect of prime-site sequence of retro-inverso-modified HTLV-1 protease inhibitor.EBI
Kyoto Prefectural University of Medicine
Design, synthesis and evaluation of γ-turn mimetics as LSD1-selective inhibitors.EBI
Kyoto Prefectural University of Medicine